Does BRCA genetic testing treat a BRCA gene mutation?

The test examines a blood or saliva sample for changes in BRCA genes. A result may help clarify inherited cancer risk, inform screening and risk-reduction discussions, and indicate whether relatives could benefit from genetic counselling. It does not repair DNA or prevent cancer by itself.

A pathogenic variant means a gene change linked with increased risk has been identified. A negative result may be reassuring when a known family variant was specifically tested, but its meaning can be less clear when no family variant is known. A variant of uncertain significance is not the same as a confirmed harmful variant and should not, on its own, drive major preventive treatment.

The report needs to be interpreted alongside personal diagnoses and family history. Genetic counselling can also explain which relatives might consider targeted testing and how results may affect emotional or family conversations.

Before testing, gather details about cancers on both sides of the family, including the type of cancer and approximate age at diagnosis. Ask what genes the test covers, what kinds of results it can return and whether a genetic counsellor will review the findings with you.

If a harmful BRCA variant is found, the care plan may include tailored screening, medicines or risk-reducing surgery depending on your circumstances and preferences. Keep a copy of the laboratory report because the exact gene and variant are needed if a relative seeks targeted testing.

A BRCA result is not usually an emergency. Arrange a timely appointment with the clinician or genetics service if the report identifies a pathogenic variant, if its wording is unclear, or if a close relative has shared a confirmed family variant.

Do not wait for genetic testing to address a new breast lump, unexplained persistent abdominal swelling, unusual bleeding or another concerning symptom. Symptom assessment follows its own clinical pathway and should proceed even while test results are pending.

Useful questions include what each possible result would mean for you, whether testing should begin with a relative who has had cancer, which screening choices might change, and how the result can be shared accurately with family members.